Derivative exercise or conversion — not an open-market buy.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Feb 14, 2026
Reporting period
Not applicable
Filed with the SEC
Feb 18, 2026
OfficerOption exercise
Context
Classification
option exercise
Code M — exercise or conversion of a derivative security
Planned / mechanical clue
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0000874716-26-000023
Filed / recorded
Feb 18, 2026, 12:30 AM UTC
Added to OQRO
Oct 2, 2026, 12:28 PM UTC
Parser
form4-xml-v1
Data quality
Verified: identifiers matched exactly
Issuer
IDEXX LABORATORIES INC /DE
Issuer CIK
874716
Ticker
IDXX
Reporting person
Michael Lane
Relationship
Officer
Officer title
Executive Vice President
Security
Restricted Stock Unit
Table
Derivative (Table II)
Transaction date
Feb 14, 2026
Transaction code
M
Shares / units
367
Price per share
$0.00
Acquired / disposed
Disposed (D)
Shares owned after
1,101
Ownership form
Direct
Amendment
No
Footnotes from the filing
Represents RSUs that were granted on February 14, 2025 and deferred in accordance with the Issuer's Deferred Compensation Plan and represents a contingent right to receive one share of Issuer common stock vesting in four annual installments, beginning February 14, 2026. Upon vesting, each such RSU will be recorded in an account under such Plan.